Halozyme Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
HALO Nasdaq 2836 halozyme.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Halozyme Therapeutics, Inc.

Compared to Estimates, Halozyme Therapeutics (HALO) Q2 Earnings: A Look at Key Metrics - Aug 6th, 2026 3:30 pm
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Surpass Estimates - Aug 6th, 2026 3:20 pm
Halozyme Therapeutics (NASDAQ:HALO) Beats Expectations in Strong Q2 CY2026, Guides for Strong Full-Year Sales - Aug 6th, 2026 2:45 pm
HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE - Aug 6th, 2026 2:01 pm
3 Growth Stocks Set to Flourish - Aug 3rd, 2026 7:25 pm
This Medical Technology Stock Claws Back To A Buy Zone - Jul 29th, 2026 11:50 am
Four Stocks Hit New Highs Amid Tech Meltdown - Jul 24th, 2026 10:55 am
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore - Jul 24th, 2026 3:13 am
Halozyme to Report Second Quarter 2026 Financial and Operating Results - Jul 23rd, 2026 6:30 am
Did Halozyme’s (HALO) New Incyte Enhanze Deal Just Redefine Its Precision Oncology Royalty Engine? - Jul 21st, 2026 9:10 am
Halozyme and Incyte sign licence agreement for INCA033989 formulations - Jul 21st, 2026 3:31 am
Halozyme Signs ENHANZE Collaboration with Incyte for Subcutaneous INCA033989 Development - Jul 20th, 2026 9:02 am
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology - Jul 20th, 2026 6:00 am
Halozyne Therapeutics (HALO) Is An Undervalued Stock That Keeps Winning In Cancer Treatment - Jul 15th, 2026 7:46 am
1 Value Stock Worth Investigating and 2 Facing Headwinds - Jul 15th, 2026 2:06 am
2 Reasons to Like HALO and 1 to Stay Skeptical - Jul 10th, 2026 10:55 am
1 Surging Stock for Long-Term Investors and 2 We Brush Off - Jul 1st, 2026 2:57 am
Halozyme Appoints David Ramsay as President Drug Delivery - Jun 30th, 2026 2:02 pm
Incyte (INCY) Surges 5.8%: Is This an Indication of Further Gains? - Jun 29th, 2026 7:54 am
ABSCI CORP (ABSI) Soars 36.0%: Is Further Upside Left in the Stock? - Jun 25th, 2026 4:18 am